Showing results (951-960 of 5,219) with videos related to
Sort By:
Pageof 522
Antiviral Research|December 3, 2020
Inhibitors of APE1 redox function effectively inhibit γ-herpesvirus replication in vitro and in vivoJiayuan Hu, Yan Wang, Yan YuanAntiviral Research|September 9, 2022
TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activityXing Tian, Huijun Dong, Xinyuan Lai, et al.Antiviral Research|October 1, 2022
Administration of the antiviral agent T-1105 fully protects pigs from foot-and-mouth disease infectionTatsuya Nishi, Katsuhiko Fukai, Kentaro Masujin, et al.Antiviral Research|September 23, 2022
Efficient rescue of a newly classified Ebinur lake orthobunyavirus with GFP reporter and its application in rapid antiviral screeningNanjie Ren, Fei Wang, Lu Zhao, et al.Antiviral Research|September 26, 2022
Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLproLing Ma, Quanjie Li, Yongli Xie, et al.Antiviral Research|September 28, 2022
Relative frequency of cytomegalovirus UL56 gene mutations detected in genotypic letermovir resistance testingSunwen Chou, Steven KleiboekerAntiviral Research|January 21, 2021
Pentostatin antagonizes the antiviral activity of MBX-2168 by inhibiting the biosynthesis of the active compoundNatalie R Hagen, Marie L Nguyen, John D Williams, et al.Antiviral Research|January 14, 2021
First report of antiviral activity of nordihydroguaiaretic acid against Fort Sherman virus (Orthobunyavirus)Florencia Martinez, María Laura Mugas, Juan Javier Aguilar, et al.Antiviral Research|March 12, 2021
Methodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patientsShi Liu, Yaobo Wu, Rui Deng, et al.Antiviral Research|March 12, 2021
Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogsYan Liu, Rongjuan Chen, Wenhui Liu, et al.Pageof 522